Constructing a Multi-Morbidity Index from Simulated Data

Slides:



Advertisements
Similar presentations
Time Between Charts Farrokh Alemi, Ph.D.. Steps in construction of time in between charts 1. Verify the chart assumptions 2. Select to draw time to success.
Advertisements

FARROKH ALEMI, PH.D. Measurement of Severity from Claims Data.
Project Control Farrokh Alemi, Ph.D. Lee Baliton.
Multiple Regression Farrokh Alemi, Ph.D. Kashif Haqqi M.D.
Discrete Probability Distributions
Farrokh Alemi, Ph.D..  Compare effectiveness  Low dose rofecoxib (Vioxx)  High dose rofecoxib (Vioxx)  Celecoxib  Other medication.
Risk Assessment Farrokh Alemi, Ph.D.. Session Objectives 1.Discuss the role of risk assessment in the TQM process. 2.Describe the five severity indices.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Time To Missed Exercise Farrokh Alemi, Ph.D.. Why do it? You need to distinguish between random days of missed exercise from real changes in underlying.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Discontinuation of medication after nonfatal event: MI
What every Family Physician needs to know about Medicare Risk Adjustment? Valerie Green-Amos, M.D., FAAFP President, J. Mario Molina M.D., P.C.
HEART AND CARDIOVASCULAR SYSTEM DISEASES
From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review.
Step 3: Thought Experiments
Probability Distributions for Discrete Variables
The APACHE III Prognostic System
Normal Distribution Farrokh Alemi Ph.D.
Progress and Promise in RAAS Blockade
Log Linear Modeling of Independence
Module 18 Pain Management Revised.
Probability Calculus Farrokh Alemi Ph.D.
Technology Mrs. Huddleston
Observations, Variables and Data Matrices
Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD 
SQL for Predicting from Likelihood Ratios
Causal Networks Farrokh Alemi, PhD.
A. Heart failure: A challenge to the healthcare delivery system
SQL for Calculating Likelihood Ratios
Types of Joins Farrokh Alemi, Ph.D.
SQL for Cleaning Data Farrokh Alemi, Ph.D.
Calculating Product of Values in Same Column
Receiver Operating Curves
Stratification Matters: Analysis of 3 Variables
Saturday, August 06, 2016 Farrokh Alemi, PhD.
Step Care Therapy for Hypertension in Diabetic Patients
Date Functions Farrokh Alemi, Ph.D.
Propagation Algorithm in Bayesian Networks
Creating Tables & Inserting Values Using SQL
Step 4: Maintain a Causal Diary
Comparing two Rates Farrokh Alemi Ph.D.
Cursors Organized by Farrokh Alemi, Ph.D. Narrated by Yara Alemi
New Tool to Help Prevent Readmissions Modified LACE Tool
Expectation And Variance of Random Variables
Comorbidity status in patients with CKD stage 4 or 5 not on dialysis, peritoneal dialysis, haemodialysis and transplanted patients (bars), as well as in.
Step 4: Maintain a Causal Diary
Wednesday, September 21, 2016 Farrokh Alemi, PhD.
Indexing & Computational Efficiency
Selecting the Right Predictors
Benchmarking Clinicians using Data Balancing
Analysis of Observed & Expected Infections
The effect of congestive heart failure on perioperative outcomes in patients undergoing lower extremity revascularization  Richard L. Amdur, PhD, Bernard.
Alik Farber, MD, Tze-Woei Tan, MD, Denis Rybin, MS, Jeffrey A
Improving Overlap Farrokh Alemi, Ph.D.
Proposal to Delay the HCC Exception Score Assignment
What is a “Run-On Statement?”
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Expectation Farrokh Alemi Ph.D.
Time between Control Chart: When Is Harm Reduction Drug Use?
Expectation And Variance of Random Variables
Benchmarking Clinicians using Data Balancing
Risk Adjusted P-chart Farrokh Alemi, Ph.D.
Adjusted ORs of AF within 30 days after bereavement with specific characteristics versus non-bereaved with the same characteristics. * *The vertical dashed.
An externally validated robust risk predictive model of adverse outcomes after carotid endarterectomy  Mohammad H. Eslami, MD, Denis Rybin, MS, Gheorghe.
Time-between Control Chart for Exercise By Farrokh Alemi Ph.D
Associations between type of MI and incident HF
Incidence Incidence of a disease is: “the rate at which new cases occur in a population in a given period, usually in the past 12 months (one calendar.
Stratified Covariate Balancing Using R
Categorical Data By Farrokh Alemi, Ph.D.
Presentation transcript:

Constructing a Multi-Morbidity Index from Simulated Data Farrokh Alemi, Ph.D.

Cases Controls Averages Just taking the average effects of each diagnosis will not do. A condition that is rare but requires long stays will have misleading results. A more careful analysis will need to match Cases with diagnosis against Controls without. Averages

Combination Length of stay Number of Patients 1 MI CHF DM 5.56 10 3 AA 5.54 4 3.56 20 5 7.03 30 6 5.02 7 5.04 8 7.62 40 3.03 2 4.10 9 2.03 11 2.60 50 12 2.57 13 0.61 60 14 2.12 70 15 0.01 80 16 4.57 120 MI = Myocardial Infarction; CHF = Congestive Heart Failure; DM=Diabetes Mellitus; AA=Alcohol abuse Here are the data we will work with. The first group of patients have three diagnosis, MI, CHF and DM. They stay on average 5.56 days. There were 10 such patients in our medical record.

Combination Length of stay Number of Patients 1 MI CHF DM 5.56 10 3 AA 5.54 4 3.56 20 5 7.03 30 6 5.02 7 5.04 8 7.62 40 3.03 2 4.10 9 2.03 11 2.60 50 12 2.57 13 0.61 60 14 2.12 70 15 0.01 80 16 4.57 120 MI = Myocardial Infarction; CHF = Congestive Heart Failure; DM=Diabetes Mellitus; AA=Alcohol abuse Note that the number of patients with different sets of diagnosis are quite different. Some combination of diagnoses occur many more times than others.

If cell c7 is CHF then assign a 1 otherwise a 0 Use the if statement to create a series of binary columns where the presence of a disease is shown as 1 and the absence as 0

Sum product of column H and F divided by sum of column H Calculate the length of stay for the cases. Do this as the product of the two columns divided by number of combinations that have MI. Since number of cases and controls are going to be matched we do not need to include the number of patients in the analysis, it will always be the same within the same combination of diagnosis.

Same as before, except now 1 minus column H Calculate the number of control but this time use 1 minus the column.

Calculate difference of cases and controls Estimate the score for each diagnosis as the difference of the length of stay of cases and controls. These scores can now be used to score the patient’s prognosis.

Sum of product of diagnoses indicators and score for the diagnoses The severity score is the sum of the diagnosis that are present. Note the $ sign so that the cell address does not change when you copy and paste it. This way you can make the score in one cell and copy to other cells.

3 Days is Shorter than length of stay specified by the patient’s severity The severity score of a patient with MI, CHF and DM predicts that they will stay longer than 3 days